药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
4-Methoxyamphetamine
Benidipine
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Benidipine.
4-Methoxyamphetamine
Melperone
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Melperone.
4-Methoxyamphetamine
Butriptyline
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Butriptyline.
4-Methoxyamphetamine
Eperisone
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Eperisone.
4-Methoxyamphetamine
Fendiline
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Fendiline.
4-Methoxyamphetamine
Indenolol
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Indenolol.
4-Methoxyamphetamine
Bedaquiline
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Bedaquiline.
4-Methoxyamphetamine
Antazoline
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Antazoline.
4-Methoxyamphetamine
Nilvadipine
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Nilvadipine.
4-Methoxyamphetamine
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Nemonoxacin.
4-Methoxyamphetamine
Telavancin
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Telavancin.
4-Methoxyamphetamine
Tucidinostat
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Tucidinostat.
4-Methoxyamphetamine
Tedisamil
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Tedisamil.
4-Methoxyamphetamine
Garenoxacin
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Garenoxacin.
4-Methoxyamphetamine
Technetium Tc-99m ciprofloxacin
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Technetium Tc-99m ciprofloxacin.
4-Methoxyamphetamine
Pracinostat
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Pracinostat.
4-Methoxyamphetamine
Azimilide
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Azimilide.
4-Methoxyamphetamine
Fluspirilene
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Fluspirilene.
4-Methoxyamphetamine
Prenylamine
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Prenylamine.
4-Methoxyamphetamine
Terlipressin
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Terlipressin.